Evidence map›Paper›PMID 41168646›Full record

ArticleInternational journal of dermatology2026

Predictive Factors of Response and Real-World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort.

Alonso García-Núñez, Antonio Alcalá Ramírez Del Puerto, Roberto Daza-García, María Teresa Monserrat-García, Mercedes Morillo-Andújar, Javier Jesús Domínguez-Cruz, Román Barabash-Neila

Abstract read
In one paragraph

Article in International journal of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alonso García-NúñezDermatology Department, Hospital Universitario Virgen del Rocío, Seville, Spain.ORCID https://orcid.org/0000-0003-2597-7400
Antonio Alcalá Ramírez Del PuertoDermatology Department, Hospital Universitario Virgen del Rocío, Seville, Spain.ORCID https://orcid.org/0009-0004-0640-2200
Roberto Daza-GarcíaDermatology Department, Hospital Universitario Virgen del Rocío, Seville, Spain.ORCID https://orcid.org/0009-0005-4402-0913
María Teresa Monserrat-GarcíaDermatology Department, Pediatric Section, Hospital Universitario Virgen del Rocío, Seville, Spain.ORCID https://orcid.org/0000-0001-9211-9161
Mercedes Morillo-AndújarDermatology Department, Hospital Universitario Virgen del Rocío, Seville, Spain.ORCID https://orcid.org/0000-0002-8207-3785
Javier Jesús Domínguez-CruzDermatology Department, Hospital Universitario Virgen del Rocío, Seville, Spain.
Román Barabash-NeilaDermatology Department, Hospital Universitario Virgen del Rocío, Seville, Spain.ORCID https://orcid.org/0009-0008-4023-4174

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alopecia areatabaricitinibpredictors of responsereal‐world experienceregrowthSALT

Identifiers

PMID41168646
PMCPMC13067332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.